FDA Import Refusal AEK-0418813-1/30002/1 — GLAXOSMITHKLINE PHARMA
The FDA refused shipment AEK-0418813-1/30002/1 from GLAXOSMITHKLINE PHARMA (India) on Jul 21, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal Details
- Date
- Jul 21, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60LCA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 75